OMEZELIS, film-coated tablet 120 tablets, CIP 3400934351358
Active ingredients: MAGNÉSIUM (LACTATE DE), MÉLISSE (FEUILLE DE) (EXTRAIT SEC DE)
Commercialized according to BDPM
Film-coated tablet120 tablets, CIP 3400934351358orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- OMEZELIS, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- tube(s) polypropylène de 120 comprimé(s) ( abrogée le 08/07/2024)
- Marketing authorisation holder
- BIOCODEX
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 27 Jun 2025
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60711128CIP73435135CIP133400934351358Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MAGNÉSIUM (LACTATE DE)comprimé | 75,00 mg · un comprimé | SA |
| MÉLISSE (FEUILLE DE) (EXTRAIT SEC DE)comprimé | 150,00 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.